Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.400 GeneticVariation group BEFREE The TT genotype for the COMT rs9332377 gene was highly associated with the presence of muscular TMD (P= 0.03). 31285095 2020
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.400 GeneticVariation group BEFREE Polymorphisms in COMT rs4818 were significantly associated with myofascial pain (OR<sub>c</sub>  = 2.15; CI 95%: 1.08-4.29; P = 0.02) and were borderline for painful TMD (OR<sub>c</sub>  = 1.85; CI 95%: 0.97-3.51; P = 0.06) and disc displacement (OR<sub>c</sub>  = 2.42; CI 95%: 1.00-5.87; P = 0.05). 30811655 2019
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.400 GeneticVariation group BEFREE µ-Opioid Activity in Chronic TMD Pain Is Associated with COMT Polymorphism. 31490699 2019
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.400 Biomarker group BEFREE The purpose of this study was to evaluate the associations of variability in pulp sensitivity with sex, psychosocial variables, the gene that encodes for the enzyme catechol-O-methyltransferase (COMT), and chronic painful conditions (temporomandibular disorders [TMDs]). 29550002 2018
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.400 AlteredExpression group BEFREE Functional pain syndromes, such as fibromyalgia and temporomandibular disorder, are associated with enhanced catecholamine tone and decreased levels of catechol-O-methyltransferase (COMT; an enzyme that metabolizes catecholamines). 29935309 2018
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.400 GeneticVariation group BEFREE Genetic Polymorphisms of Catechol-O-Methyltransferase: Association with Temporomandibular Disorders and Postoperative Pain. 27792797 2017
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.400 Biomarker group BEFREE Furthermore, a significant (P = 0.04) interaction of COMT diplotype and time-varying stress showed that a postbaseline increase of 1.0 standard deviation in PSS more than doubled risk of TMD incidence in subjects with low-activity COMT diplotypes (hazard ratio = 2.35; 95% confidence limits: 1.66, 3.32), an effect not found in subjects with high-activity COMT diplotypes (hazard ratio = 1.42; 95% confidence limits: 0.96, 2.09). 26198390 2015
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.400 GeneticVariation group BEFREE Results show that the COMT rs4680 (rs4680;s4680;rs1200746244" genes_norm="1312;4524">val(158)met) polymorphism is most strongly associated with outcome measures, such that individuals with the minor A allele (met) exhibit reduced COMT activity, increased TMD risk, and increased musculoskeletal pain. 25218601 2014
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.400 Biomarker group CTD_human Results show that the COMT rs4680 (val(158)met) polymorphism is most strongly associated with outcome measures, such that individuals with the minor A allele (met) exhibit reduced COMT activity, increased TMD risk, and increased musculoskeletal pain. 25218601 2014
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.400 GeneticVariation group BEFREE Our data extend the number of SNPs present in the promoter region that could play a regulatory role in COMT gene and suggest that the genetic polymorphisms rs 165656 and rs 4646310 exert a role in TMD susceptibility. 23446089 2014
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.400 GeneticVariation group BEFREE Cross-sectional data from the population-based Study of Health in Pomerania (SHIP) in Germany were used to estimate additive interactions between depressive symptoms and 22 single-nucleotide polymorphisms (SNPs) of the COMT gene and the neighbouring thioredoxin reductase 2 (TXNRD2) gene on TMD pain. 22337325 2012
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.400 Biomarker group BEFREE The OPPERA findings provided evidence supporting previously reported associations between TMD and 2 genes: HTR2A and COMT. 22074755 2011
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.400 GeneticVariation group BEFREE Forty Caucasian female participants meeting the Research Diagnostic Criteria for TMD were genotyped for COMT polymorphisms and completed a randomized, double-blind, placebo-controlled, two-period crossover pilot study. 20216107 2010
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.400 GeneticVariation group BEFREE Recently, our group demonstrated that three common haplotypes of the human COMT gene, divergent in two synonymous and one nonsynonymous position, are associated with experimental pain sensitivity and onset of temporomandibular joint disorder. 20336436 2010
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.400 GeneticVariation group BEFREE Nonsynonimous mutation of catechol-O-methyl-transferase (COMT) gene in a patient with temporomandibular disorder. 20974455 2010
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.400 GeneticVariation group BEFREE Psychological factors linked to pain sensitivity influenced TMD risk independently of the effects of the COMT haplotype on TMD risk. 17959908 2007
Entrez Id: 2475
Gene Symbol: MTOR
MTOR
0.200 Biomarker group RGD Enhancement of chondrocyte autophagy is an early response in the degenerative cartilage of the temporomandibular joint to biomechanical dental stimulation. 23386193 2013
Entrez Id: 84557
Gene Symbol: MAP1LC3A
MAP1LC3A
0.200 Biomarker group RGD Enhancement of chondrocyte autophagy is an early response in the degenerative cartilage of the temporomandibular joint to biomechanical dental stimulation. 23386193 2013
Entrez Id: 8678
Gene Symbol: BECN1
BECN1
0.200 Biomarker group RGD Enhancement of chondrocyte autophagy is an early response in the degenerative cartilage of the temporomandibular joint to biomechanical dental stimulation. 23386193 2013
Entrez Id: 8491
Gene Symbol: MAP4K3
MAP4K3
0.200 Biomarker group RGD Enhancement of chondrocyte autophagy is an early response in the degenerative cartilage of the temporomandibular joint to biomechanical dental stimulation. 23386193 2013
Entrez Id: 3091
Gene Symbol: HIF1A
HIF1A
0.200 Biomarker group RGD Activation of the hypoxia-inducible factor-1 in overloaded temporomandibular joint, and induction of osteoclastogenesis. 20171183 2010
Entrez Id: 7273
Gene Symbol: TTN
TTN
0.100 Biomarker group BEFREE 136 participants with at least one of four orofacial pain diagnoses (temporomandibular disorders [TMD, n = 41], acute dental pain [ADP, n = 41], trigeminal neuralgia [TN, n = 19], persistent dentoalveolar pain disorder [PDAP, n = 14]) and a group of pain-free controls (n = 21) completed the modified S-LANSS, a previously adapted version of the original questionnaire devised to detected patients suffering from intraoral pain with neuropathic characteristics. 27981266 2017
Entrez Id: 7273
Gene Symbol: TTN
TTN
0.100 Biomarker group BEFREE TMD sign using the Research Diagnostic Criteria for Temporomandibular Disorders and TMD pain intensity using a visual analog scale (VAS) in the morning and daytime were evaluated at baseline (pre-exercise) and at 2-weeks, 1-month, and 3-months after OA insertion. 28063976 2017
Entrez Id: 57597
Gene Symbol: BAHCC1
BAHCC1
0.100 GeneticVariation group GWASCAT GWAS Identifies New Loci for Painful Temporomandibular Disorder: Hispanic Community Health Study/Study of Latinos. 28081371 2017
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 GeneticVariation group GWASCAT GWAS Identifies New Loci for Painful Temporomandibular Disorder: Hispanic Community Health Study/Study of Latinos. 28081371 2017